Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. - Wikidata - awgldk - TriplyDB

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.

http://www.wikidata.org/entity/Q45198841

about

Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults Lung transplantation for cystic fibrosis Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.Breath sulfides and pulmonary function in cystic fibrosis Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease Potential of anti-inflammatory treatment for cystic fibrosis lung disease.Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2003.Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis.Inflammatory markers of lung disease in adult patients with cystic fibrosis.Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy Sputum induction improves detection of pathogens in children with cystic fibrosis.Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference.Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.New insights into pulmonary inflammation in cystic fibrosis.Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.Sputum biomarkers of inflammation in cystic fibrosis lung disease Potential role of high-mobility group box 1 in cystic fibrosis airway disease.Circulating RNA transcripts identify therapeutic response in cystic fibrosis lung disease A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate Progress in cystic fibrosis and the CF Therapeutics Development Network Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis.Association between pulmonary function and sputum biomarkers in cystic fibrosis.Extracellular purines are biomarkers of neutrophilic airway inflammation.Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation Novel outcome measures for clinical trials in cystic fibrosis Emerging Roles of Carbonyl Sulfide in Chemical Biology: Sulfide Transporter or Gasotransmitter?Biomarkers for cystic fibrosis drug development.Cystic Fibrosis: Microbiology and Host Response Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center.

P2860

Q24187890-A7DA6557-C97B-42EB-8222-476F690EEA1C Q28749501-3B8278C4-1521-4C78-A60E-57C2EE6C95F8 Q33611238-B19D63AE-CBC8-4600-B048-B760C5723A32 Q33744911-C713570F-7291-4635-906D-5DC51ED16FF1 Q33836925-E2249BF3-F007-4296-BF35-AED4BF7ED9D4 Q34116010-2A4DB6D1-6B9D-4E3F-9339-3030880CFF67 Q34480471-F8E1CAD5-2E35-410B-9F84-62A8B8C3BCB2 Q34706914-532DC3F1-0630-422F-A02A-F9B29887748F Q35143420-022113F5-56C9-4CE3-AEA1-99B4177F6888 Q35164509-BE31D78B-C928-45A6-9F91-07DB17B18F10 Q35557381-44D36840-1B60-4E26-9AA0-09A879371448 Q35565168-49C23B30-D948-4855-8A9F-6365DA791626 Q35626617-D176ECEA-FBF9-43D6-A396-5823E0314CAF Q35675928-95658D13-B3E6-40B3-B1A0-A3432BA5F767 Q35684772-186B64A3-DC45-489C-88D2-934DED888099 Q35741301-E1A85987-7966-46DE-BF74-32AFA4B23F99 Q35749974-37FFD6A4-ED1D-4704-84C5-FD18908CE34D Q35817400-4B57E19E-5203-4D56-BB8D-55DA21C27380 Q35828811-16ADBAE5-B863-4468-BDCB-E4FC5B044DBD Q35836325-DE2DFEA2-FD3B-4533-B957-C03213CD2553 Q36274154-71FC0BDB-8C8E-45BD-A432-305537C745EC Q36571855-04F693D0-2A37-42FC-B1A3-7323864D6A34 Q36573117-4D3122F0-1CC1-482A-AEB6-572780051E61 Q36771148-D0E2D912-8AC3-49B2-81A5-24E617735FE7 Q36891552-0A94D155-3C74-4B7C-BE7E-E8730E210BFA Q36935244-11F2CCFD-2521-4B36-AD4C-5B2EB86B6634 Q36960790-9DA1001B-40CF-4E6B-AFA3-7D7A791A6686 Q36962710-0BBB711D-AF81-4270-8FA9-0AFC1D9C5542 Q37209004-B3363445-47A9-49C9-9F5E-1C68E65DA517 Q37218032-6720E4D1-75E6-4344-A535-0FB3D34C4BA4 Q37287157-0154E794-499A-44FD-B39D-96ADB2C45D04 Q37297168-E28498E4-F2AE-4A22-BF5C-24BECBB24239 Q37377689-E99F29B8-6666-4A0B-8D42-947E38D29572 Q37463875-04CE5A5F-A980-4125-A863-6C86CD556825 Q37721498-270E5ACD-95CB-4D41-A723-8FE05E2A64C2 Q38340406-3AD2926C-2B45-45FE-BD70-82B29116D45B Q38690809-10BC93D2-D6AE-4B88-B57A-C04656842122 Q38755600-0341480A-A7B2-4A96-8902-5C241B487278 Q38911644-B9FF685A-C722-484C-AB6D-D82E3F351433 Q39514745-969C4CC7-F28D-472B-9E83-09B36E5AE55C

P2860

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.

http://www.wikidata.org/entity/Q45198841

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Inflammatory and microbiologic ...... ntibiotics in cystic fibrosis.

@en

Inflammatory and microbiologic ...... ntibiotics in cystic fibrosis.

@nl

type

label

Inflammatory and microbiologic ...... ntibiotics in cystic fibrosis.

@en

Inflammatory and microbiologic ...... ntibiotics in cystic fibrosis.

@nl

prefLabel

Inflammatory and microbiologic ...... ntibiotics in cystic fibrosis.

@en

Inflammatory and microbiologic ...... ntibiotics in cystic fibrosis.

@nl

P1433

Q45198841-BD770C4B-1C4F-4646-BA6F-1930CABA4883

P1476

Q45198841-3F860477-9C41-43D8-A93C-1E2C4DB470E3

P2093

Q45198841-0DB68AD2-F9F7-4E06-B650-B357E1B846E8

Q45198841-0EE342B0-9041-420A-B77E-56F620BD5F2D

Q45198841-22F13485-66B3-473E-A388-B613BA05BBDC

Q45198841-36858FA2-1711-421E-AC3D-3C77DBB77B21

Q45198841-5BF9CABF-C899-41B4-9FE7-01AF1E48F1D3

Q45198841-61BB6DAF-8542-41FC-8E0E-1FBE15FCA8B3

Q45198841-65293A2F-398C-4264-A3DF-4CFCADB4D29F

Q45198841-78DE5D73-67B8-46C2-92B3-2ABD7E5D66AA

Q45198841-7E5732FE-41EE-4AC5-BD0C-763C879FBCDA

Q45198841-A368CB4D-A927-450A-8577-F9EF5CB6D06F

P2860

Q45198841-0E4EDCC8-A40C-4D85-A3C0-B225A415DB0D

Q45198841-1864F7D5-AA87-4B15-9810-0540F317C335

Q45198841-2CEBFC09-48F6-4721-AD64-5CC4489EFBED

Q45198841-2FA1801B-C1A3-4054-AA8F-A2CB154411B7

Q45198841-3068A67C-2F14-4501-B4D6-2FD09F8984BB

Q45198841-34403DAC-DB8E-4C70-9505-56FF0E4DAA0F

Q45198841-37E7819D-2606-4796-BEA3-22284AC7B3A3

Q45198841-481C1319-DF2B-41E9-B352-8A4D89D16636

Q45198841-4AC5E70D-379C-4D18-A96C-103767078256

Q45198841-6418613F-13D6-4314-97FE-3EFAE5809C95

P304

Q45198841-7E2DB0B1-868C-4AA0-A755-4FC5AD98E205

P31

Q45198841-09DDBB26-4809-46EB-9DF9-5A47603365CE

P356

Q45198841-E4A92541-C3AA-4177-863A-3360EAEC41FD

P407

Q45198841-2E89858F-E736-4E16-8212-565C26047025

P433

Q45198841-09F872A0-A7B9-49C6-8E6A-A3D239E73BD8

P478

Q45198841-020D9C75-C8B2-421F-A86C-8470ABAE9487

P50

Q45198841-832412AF-71EC-4ED2-81D8-EC59A4C49833

P577

Q45198841-4DA50843-779A-4C6A-BD3A-E2E3BA947C27

P698

Q45198841-792151D9-234C-4D27-B54A-89DB4902661E

P921

Q45198841-1E04A512-3FEA-415F-BAB6-495047736AFE

Q45198841-23E121EB-F261-4754-89AC-F67480F21A37

Q45198841-D15AA835-3FF4-40C8-8DAD-9B1BB0F70E6A

P356

RCCM.200306-731OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Inflammatory and microbiologic ...... ntibiotics in cystic fibrosis.

@en

P2093

Claudia L Ordoñez

http://www.w3.org/2001/XMLSchema#string

Cori L Daines

http://www.w3.org/2001/XMLSchema#string

Frank J Accurso

http://www.w3.org/2001/XMLSchema#string

George Z Retsch-Bogart

http://www.w3.org/2001/XMLSchema#string

James F Chmiel

http://www.w3.org/2001/XMLSchema#string

Jane L Burns

http://www.w3.org/2001/XMLSchema#string

Moira L Aitken

http://www.w3.org/2001/XMLSchema#string

Nicole Mayer-Hamblett

http://www.w3.org/2001/XMLSchema#string

Noreen R Henig

http://www.w3.org/2001/XMLSchema#string

Ronald L Gibson

http://www.w3.org/2001/XMLSchema#string

P2860

Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis

Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease.

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Early airway infection, inflammation, and lung function in cystic fibrosis.

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis.

Inflammatory cytokines in cystic fibrosis lungs.

Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease.

Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.

P304

1471-1475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200306-731OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12969869

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis